Skip to main content
Livermore
Livermore
ZHEN

Zynerba Pharmaceuticals, Inc.

ZYNEDelisted Oct 11, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001621443

Zynerba Pharmaceuticals, Inc. was delisted on Oct 11, 2023; its insiders filed their last Form 4 on Oct 11, 2023; 43 institutions reported holding it in 13F filings for Q3 2023, worth $14.7M in total; no superinvestor held it.

13F holders, Q1 2023

Institutional positions in Zynerba Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
44
−5 vs. Q4 2022
Shares held
6.41M
−1.54M (−19.3%) vs. Q4 2022
Total value
$2.75M
−$1.45M (−34.6%) vs. Q4 2022
New holders
5
7 more added
Sold out
10
13 more reduced

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ZYNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 44 institutions
Q1 2021: 67 institutionsQ2 2021: 65 institutionsQ3 2021: 59 institutionsQ4 2021: 62 institutionsQ1 2022: 59 institutionsQ2 2022: 56 institutionsQ3 2022: 62 institutionsQ4 2022: 50 institutionsQ1 2023: 44 institutionsQ2 2023: 41 institutionsQ3 2023: 43 institutionsQ4 2023: 0 institutionsQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2023: $2.75M
Q1 2021: $42.1MQ2 2021: $78.1MQ3 2021: $57.1MQ4 2021: $38.3MQ1 2022: $24.8MQ2 2022: $12.5MQ3 2022: $7.97MQ4 2022: $4.23MQ1 2023: $2.75MQ2 2023: $1.74MQ3 2023: $14.7MQ4 2023: $0Q1 2024: $16.2KQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ZYNE and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$16.2K
Q4 20230$0
Q3 202343$14.7M
Q2 202341$1.74M
Q1 202344$2.75M
Q4 202250$4.23M
Q3 202262$7.97M
Q2 202256$12.5M
Q1 202259$24.8M
Q4 202162$38.3M
Q3 202159$57.1M
Q2 202165$78.1M
Q1 202167$42.1M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Zynerba Pharmaceuticals, Inc.; share changes are against Q4 2022.

Institutions holding ZYNE in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Tower Research Capital LLC (TRC)84$00.00%−14,949−99.4%Reduced
Simplex Trading, LLC2,274$00.00%−1,393−38.0%Reduced
Lindbrook Capital, LLC1$00.00%00.0%Unchanged
Iron Horse Wealth Management, LLC1$00.00%00.0%Unchanged
GHP Investment Advisors, Inc.1$10.00%00.0%Unchanged
HM Payson & Co50$220.00%00.0%Unchanged
Harbour Investments, Inc.100$430.00%00.0%Unchanged
Kistler-Tiffany Companies, LLC100$430.00%00.0%Unchanged
FMR LLC175$750.00%+175New
Bank of America Corp200$860.00%+48+31.6%Added
Huntington National Bank217$930.00%00.0%Unchanged
Sound Income Strategies, LLC350$1510.00%00.0%Unchanged
Proequities, Inc.501$2150.00%00.0%Unchanged
Ahrens Investment Partners LLC1,040$4470.00%+1,040New
Founders Capital Management2,000$1.00K0.00%00.0%Unchanged
Group One Trading, L.P.4,559$1.96K0.00%−1,500−24.8%Reduced
JPMorgan Chase & Co3,739$2.00K0.00%+3,227+630.3%Added
Newbridge Financial Services Group, Inc.6,075$2.61K0.00%00.0%Unchanged
Key Financial Inc7,500$3.23K0.00%00.0%Unchanged
Royal Bank of Canada10,831$5.00K0.00%+10,631+5,315.5%Added
Raymond James Financial Services Advisors, Inc.14,200$6.11K0.00%+14,200New
King Wealth16,000$7.00K0.00%00.0%Unchanged
HRT Financial LP19,760$8.00K0.00%+19,760New
Cetera Advisor Networks LLC24,260$10.4K0.00%00.0%Unchanged
UBS Group AG30,286$13.0K0.00%−11,734−27.9%Reduced
Virtu Financial LLC32,386$14.0K0.00%+32,386New
Advisor Group Holdings, Inc.37,609$15.5K0.00%+6,250+19.9%Added
Bank of New York Mellon Corp36,562$15.7K0.00%−100−0.3%Reduced
Charles Schwab Investment Management Inc37,596$16.2K0.00%00.0%Unchanged
Bernardo Wealth Planning LLC38,578$16.6K0.01%00.0%Unchanged
Morgan Stanley43,614$18.8K0.00%−4,005−8.4%Reduced
Bridgeway Capital Management, LLC65,900$28.3K0.00%−50,000−43.1%Reduced
Two Sigma Investments, LP70,170$30.2K0.00%−900−1.3%Reduced
Northern Trust Corp115,210$49.5K0.00%−1,547−1.3%Reduced
State Street Corp119,741$51.5K0.00%00.0%Unchanged
Two Sigma Advisers, LP144,900$62.3K0.00%−41,100−22.1%Reduced
Wells Fargo & Company146,733$63.1K0.00%+88,629+152.5%Added
Penserra Capital Management LLC219,146$94.0K0.00%+3,424+1.6%Added
Geode Capital Management, LLC387,346$166.6K0.00%00.0%Unchanged
Millennium Management LLC456,349$196.0K0.00%−103,789−18.5%Reduced
Renaissance Technologies LLC569,700$245.0K0.00%−270,800−32.2%Reduced
ETF Managers Group, LLC723,151$311.0K0.01%−787,721−52.1%Reduced
BlackRock Inc.838,702$360.6K0.00%+2,582+0.3%Added
Vanguard Group Inc2,179,600$937.2K0.00%00.0%Unchanged
D. E. Shaw & Co., Inc.0$00.00%−195,064−100.0%Sold out
Davy Global Fund Management Ltd0$00.00%−122,892−100.0%Sold out
Jane Street Group, LLC0$00.00%−38,984−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−34,141−100.0%Sold out
Exchange Traded Concepts, LLC0$00.00%−18,733−100.0%Sold out
Citadel Advisors LLC0$00.00%−17,471−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−2,000−100.0%Sold out
Citigroup Inc0$00.00%−100−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−3−100.0%Sold out
Massmutual Trust Co FSB0$00.00%−150−100.0%Sold out
Zeke Capital Advisors, LLC––––Not filed